tiprankstipranks
BeiGene price target raised to $262 from $213 at Cowen
The Fly

BeiGene price target raised to $262 from $213 at Cowen

Cowen analyst Yaron Werber raised the firm’s price target on BeiGene to $262 from $213 and keeps an Outperform rating on the shares. The analyst said Q4 product revenues were hit by COVID in China but we remain optimistic about Brukinsa given its best-in-class profile and US approval in CLL.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on BGNE:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles